Pyxis Oncology (PYXS)
(Delayed Data from NSDQ)
$3.75 USD
+0.52 (16.10%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $3.80 +0.05 (1.33%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Pyxis Oncology, Inc. (PYXS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.20 | $12.00 | $7.00 | 184.83% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Pyxis Oncology, Inc. comes to $9.20. The forecasts range from a low of $7.00 to a high of $12.00. The average price target represents an increase of 184.83% from the last closing price of $3.23.
Analyst Price Targets (5 )
Broker Rating
Pyxis Oncology, Inc. currently has an average brokerage recommendation (ABR) of 1.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.13 a month ago based on eight recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 85.71% and 14.29% of all recommendations. A month ago, Strong Buy made up 87.5%, while Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 7 | 7 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.14 | 1.14 | 1.13 | 1.13 | 1.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/15/2024 | SVB Securities | Jeffrey La Rosa | Strong Buy | Strong Buy |
8/16/2024 | H.C. Wainwright & Co. | Swayampakula Ramakanth | Strong Buy | Strong Buy |
8/14/2024 | William Blair | Andy T Hsieh | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/26/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/15/2024 | LifeSci Capital | Sam Slutsky | Strong Buy | Strong Buy |
5/7/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.14 |
ABR (Last week) | 1.14 |
# of Recs in ABR | 7 |
Average Target Price | $9.20 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 71 of 252 |
Current Quarter EPS Est: | -0.32 |
PYXS FAQs
Pyxis Oncology, Inc. (PYXS) currently has an average brokerage recommendation (ABR) of 1.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Pyxis Oncology, Inc. (PYXS) is $9.20. The current on short-term price targets is based on 5 reports.
The forecasts for Pyxis Oncology, Inc. (PYXS) range from a low of $7 to a high of $12. The average price target represents a increase of $145.33 from the last closing price of $3.75.
The current UPSIDE for Pyxis Oncology, Inc. (PYXS) is 145.33%
Based on short-term price targets offered by five analysts, the average price target for Pyxis Oncology, Inc. comes to $9.20. The forecasts range from a low of $7.00 to a high of $12.00. The average price target represents an increase of 184.83% from the last closing price of $3.23.